Al Sandrock is one of the most celebrated drug developers of his generation. Yet his much anticipated Alzheimer's drug failed like so many before it. Stat takes a look at that day he found out, and why this mystery is so hard to crack. In other public health news: climate change, mammograms, debt, bullying, and screen time.
from Kaiser Health News http://bit.ly/2Z8fa9j
June 06, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Feds Say Hospitals That Redistribute Medicaid Money Violate LawThe Biden administration wants to crack down on private arrangements among some hospitals to reimburse themselves for taxes that help fund coverage for low-income people. It contends the practice violates federal law. Federal… Read More
KFF Health News' 'What the Health?': Abortion Pill’s Legal Limbo ContinuesThe Host Julie Rovner KFF Health News @jrovner Read Julie's stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health … Read More
A Peek at Big Pharma’s Playbook That Leaves Many Americans Unable to Afford Their DrugsAmerica’s pharmaceutical giants are suing this summer to block the federal government’s first effort at drug price regulation. Last year’s Inflation Reduction Act included what on its face seems a modest proposal: The federal… Read More
Community With High Medical Debt Questions Its Hospitals’ Charity SpendingPUEBLO, Colo. — As 41% of American adults face medical debt, residents of this southern Colorado city contend their local nonprofit hospitals aren’t providing enough charity care to justify the millions in tax breaks they rec… Read More
An Arm and a Leg: How a Surprise Bill Can Hitch a Ride to the HospitalHow did three siblings who took identical ambulance rides (from the same car wreck to the same hospital) end up with three wildly different bills? The answer lies in the No Surprises Act. That law has protected patients from … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment